Wilson Disease Copper Marker

Overview

The Wilson disease copper marker typically refers to non-ceruloplasmin-bound copper (free copper) in serum, calculated as total serum copper minus ceruloplasmin-bound copper. Copper is an essential trace element involved in enzymatic reactions, but excess free copper accumulation due to ATP7B gene mutations in Wilson disease leads to toxic effects in liver, brain, and other tissues. Elevated free copper levels indicate Wilson disease, while low levels may occur in conditions like malnutrition or hypoceruloplasminemia. Clinically, free copper measurement is useful for screening, diagnosis confirmation alongside other tests (e.g., ceruloplasmin, urinary copper), and monitoring treatment response with chelators like penicillamine.

Clinical Use Cases

  • Screening for Wilson disease in patients with liver dysfunction, neurological symptoms, or Kayser-Fleischer rings.
  • Confirming diagnosis when combined with low ceruloplasmin and elevated 24-hour urinary copper.
  • Monitoring therapeutic efficacy of copper chelators (e.g., D-penicillamine, trientine) or zinc therapy.
  • Assessing disease progression or recurrence post-liver transplantation.
  • Differentiating Wilson disease from other causes of liver disease in pediatric and adult patients.

Specimen Types

  • Serum (for total copper and ceruloplasmin measurement to calculate free copper).
  • Plasma (less common, must match ceruloplasmin sample type).
  • 24-hour urine (for total copper excretion as complementary test).

Measurement Methods

  • Atomic absorption spectroscopy (AAS) or inductively coupled plasma mass spectrometry (ICP-MS) for serum total copper.
  • Immunoassay or enzymatic assay for ceruloplasmin concentration.
  • Calculation of non-ceruloplasmin-bound copper (free copper = total Cu – [ceruloplasmin × 3]).
  • 24-hour urinary copper excretion by AAS or ICP-MS.

Test Preparation and Influencing Factors

  • Avoid copper-containing supplements, denture creams, or high-copper foods for 24-48 hours prior.
  • Recent chelation therapy (e.g., penicillamine) can transiently lower serum copper and elevate urinary copper.
  • Sample contamination from trace copper in collection tubes or reagents affects results.
  • Inflammation or acute phase response may alter ceruloplasmin levels, impacting free copper calculation.
  • Hemolysis or lipemia interferes with copper assays.
  • No fasting required, but collect morning sample for consistency.

Synonyms

  • Free copper.
  • Non-ceruloplasmin-bound copper (NCC).
  • Exchangeable copper.
  • Serum non-ceruloplasmin-bound copper.

Further Reading